Bill > A00026

This bill prohibits Medicaid service providers, managed care providers, and state public health plans from requiring prior authorization for antiretroviral prescription drugs used to treat or prevent HIV/AIDS. Prior authorization is a process where healthcare providers must obtain approval from an insurance company before a specific medication can be prescribed, which can create barriers to timely access to medication. By removing this requirement specifically for HIV/AIDS medications, the bill aims to ensure that patients can more quickly and easily obtain these critical drugs, which are essential for managing the virus, preventing its transmission, and maintaining patient health. The bill will take effect 180 days after becoming law, giving healthcare systems time to adjust their processes. This legislation is significant because it reduces administrative obstacles that might otherwise delay or prevent patients from receiving necessary HIV treatment and prevention medications, potentially improving health outcomes for individuals living with or at risk of HIV/AIDS.

Budget and Finance, Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A26